Literature DB >> 2500199

Intralesional tumour necrosis factor combined with interferon gamma in metastatic melanoma.

S Retsas1, M Leslie, D Bottomley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2500199      PMCID： PMC1836516          DOI： 10.1136/bmj.298.6683.1290

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

Review 1.  Tumour necrosis factor.

Authors:  S Malik; F R Balkwill
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-30

2.  A phase I trial of intravenously-administered recombinant tumor necrosis factor-alpha in cancer patients.

Authors:  B Feinberg; R Kurzrock; M Talpaz; M Blick; S Saks; J U Gutterman
Journal:  J Clin Oncol       Date:  1988-08       Impact factor: 44.544
  2 in total
  7 in total

1.  Synergistic cytotoxicity of human recombinant tumour necrosis factor alpha combined with microtubule effectors.

Authors:  J Baumgart; B Schlott; J Suehnel; W Vater; W Schulze; D Behnke
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

2.  In transit metastases of malignant melanoma treated by high dose rTNF alpha in combination with interferon-gamma and melphalan in isolation perfusion.

Authors:  D Liénard; F J Lejeune; P Ewalenko
Journal:  World J Surg       Date:  1992 Mar-Apr       Impact factor: 3.352

3.  A YIGSR-containing novel mutein without the detrimental effect of human TNF-alpha of enhancing experimental pulmonary metastasis.

Authors:  K Miyata; M Kato; H Shikama; K Nishimura; N Sakae; K Kawagoe; T Nishikawa; K Kuroda; K Yamaguchi; Y Aoyama
Journal:  Clin Exp Metastasis       Date:  1992-07       Impact factor: 5.150

4.  Tumor necrosis factor alpha modifies resistance to interferon alpha in vivo: first clinical data.

Authors:  T Moritz; O Kloke; M Nagel-Hiemke; G Kummer; U B Wandl; B Opalka; B Plappert; J Kempeni; S Seeber; N Niederle
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

5.  Tumor necrosis factor-alpha inhibits stem cell factor-induced proliferation of human bone marrow progenitor cells in vitro. Role of p55 and p75 tumor necrosis factor receptors.

Authors:  L S Rusten; E B Smeland; F W Jacobsen; E Lien; W Lesslauer; H Loetscher; C M Dubois; S E Jacobsen
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

Review 6.  Intratumoral therapies and in-situ vaccination for melanoma.

Authors:  Laura A Huppert; Adil I Daud
Journal:  Hum Vaccin Immunother       Date:  2022-05-31       Impact factor: 4.526

7.  Establishment of a human fibroblast cell line producing tumor necrosis factor alpha (KMST-6/TNF) and growth inhibitory effects of its conditioned medium on malignant cells in culture.

Authors:  K Fushimi; K Torigoe; H Yamauchi; S Furusako; M Kurimoto; M Namba
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-06       Impact factor: 2.723
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.